Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MRNX

Defiance Daily Target 2X Long MRNA ETF

May 01 • 04:00PM ET

20.23

-0.54 -2.61 %

Financial • Exchange Traded Fund • USA • NYSE

Category	Equity - Leveraged / Inverse	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	-	Total Holdings	6	Perf Week	-20.88%
Sponsor	Defiance ETFs	ETF Type		Tags	single-asset	Return% 3Y	-	AUM	415.99K	Perf Month	-20.46%
Fund Family		Bond Type		Tags	MRNA	Return% 5Y	-	NAV/sh		Perf Quarter	-
Index	-	Average Maturity		Tags	leverage	Return% 10Y		52W High	39.53 -48.83%	Perf Half Y	-
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	14.95 35.32%	Perf YTD	-0.71%
Active/Passive		Quant Type		Tags	-	Flows% 1M	-55.76%	Volatility	7.98% 6.07%	Perf Year	-
Dividend TTM	-	ESG Type		Tags	-	Flows% 3M	-64.71%	ATR (14)	2.21	Perf 3Y	-
Dividend Ex-Date	-	Dividend Type		Sector/Theme		Flows% YTD	-64.71%	RSI (14)	33.92	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	-	Perf 10Y	-
Expense	1.31%	Growth/Value		SMA20	-22.52%	Flows% 3Y		Rel Volume	3.05	Prev Close	20.77
Inverse/Leveraged		Market Cap		SMA50	-26.89%	Flows% 5Y		Avg Volume	10.81K	Price	20.23
IPO	Feb 04, 2026	Option/Short	No / Yes	SMA200	-23.25%	Trades		Volume	33,008	Change	-2.61%

Feb-09-26 04:08PM

Betting On Moderna? This New Defiance ETF Turns The Volume Up 2X

(Benzinga)

Defiance Daily Target 2X Long MRNA ETF is an actively managed, single-stock leveraged exchange-traded fund designed to provide 200% of the daily share price performance of Moderna, Inc. (MRNA). The fund is intended for sophisticated investors and active traders who seek to express tactical bullish views on mRNA-based biotechnology innovation through amplified daily exposure.

open in yahoo | open in marketwatch | open in google

MRNX

Defiance Daily Target 2X Long MRNA ETF

Upgrade your Finviz experience